2 Jung M, Holmqvist A, Sun XF, Albertsson M. A clinical study of metastasized rectal cancer treatment: assessing a multimodal approach. Med Oncol. 2014;31:839.
4 Chong G, Cunningham D. Improving long-term outcomes for patients with liver metastases from colorectal cancer. J Clin Oncol. 2005;23:9063-6.
6 Seymour MT, Maughan TS, Ledermann JA, Topham C, James R, Gwyther SJ, et al. Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial. Lancet. 2007;370:143-52.
7 Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery. 1986;100:278-84.
8 Steele G, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg. 1989;210:127-38.
10 Hebbar M, Pruvot FR, Romano O, Triboulet JP, de Gramont A. Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer. Cancer Treat Rev. 2009;35:668-75.
11 Yang AD, Brouquet A, Vauthey JN. Erweiterung der Resektionsgrenzen bei metastasiertem kolorektalem Karzinom: Risiko-Nutzen-Verhältnis. J Surg Oncol. 2010;102:996-1001.
12 Adam R. Developing strategies for liver metastases from colorectal cancer. Semin Oncol. 2007;34(Suppl. 1):S7-11.
14 Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, et al. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Rektumkarzinom. J Natl Compr Canc Netw. 2009;7:838-81.
15 Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012;17:1225-39.
16 Reddy SK, Pawlik TM, Zorzi D, Gleisner AL, Ribero D, Assumpcao L, et al. Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol. 2007;14:3481-91.
17 Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002;235:449-57.
18 Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26:303-12.
19 Porter GA, Urquhart RL, Rheaume D, Cwajna S, Cox MA, Grunfeld E. Clinical information available to oncologists in chirurgically treated rectal cancer: room to improve. Curr Oncol. 2013;20:166-72.
21 Lykoudis PM, O’Reilly D, Nastos K, Fusai G. Systematic review of surgical management of synchronous colorectal liver metastases. Br J Surg. 2014;101:605-12.
23 Bird T, Michael M, Bressel M, Chu J, Chander S, Cooray P, et al. FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases. Acta Oncol. 2017;56:646-52.
24 Chiappa A, Bertani E, Makuuchi M, Zbar AP, Contino G, Viale G, et al. Neoadjuvante Chemotherapie gefolgt von Hepatektomie bei primär resektablen Lebermetastasen des kolorektalen Karzinoms. Hepatogastroenterology. 2009;56:829-34.
25 Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, et al. Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival. Br J Surg. 2013;100:1777-83.
27 Azoulay D, Castaing D, Krissat J, Smail A, Hargreaves GM, Lemoine A, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg. 2000;232:665-72.
28 Mentha G, Majno P, Terraz S, Rubbia-Brandt L, Gervaz P, Andres A, et al. Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour. Eur J Surg Oncol. 2007;33(Suppl. 2):S76-83.
29 Yoo PS, Lopez-Soler RI, Longo WE, Cha CH. Leberresektion bei metastasiertem kolorektalem Karzinom im Zeitalter von neoadjuvanter Chemotherapie und Bevacizumab. Clin Colorectal Cancer. 2006;6:202-7.
30 Elias D, De Baere T, Smayra T, Ouellet JF, Roche A, Lasser P. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg. 2002;89:752-6.
32 Lam VW, Laurence JM, Johnston E, Hollands MJ, Pleass HC, Richardson AJ. A systematic review of two-stage hepatectomy in patients with initially inresectable colorectal liver metastases. HPB (Oxford). 2013;15:483-91.
33 Popescu I, Alexandrescu ST. Chirurgische Optionen bei initial nicht resektablen kolorektalen Lebermetastasen. HPB Surg. 2012;20:454026.
34 van Lienden KP, van den Esschert JW, de Graaf W, Bipat S, Lameris JS, van Gulik TM, et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol. 2013;36:25-34.
35 Gérard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, Closon-Dejardin MT, et al. Präoperative Strahlentherapie mit oder ohne gleichzeitiges Fluorouracil und Leucovorin bei T3-4 Rektumkarzinomen: Ergebnisse von FFCD 9203. J Clin Oncol. 2006;24:4620-5.
38 Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994;343:1405-10.
39 Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94:982-99.
40 Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol. 2001;8:347-53.
41 Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. Rescue surgery for inresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644-57.
45 Slesser AA, Bhangu A, Brown G, Mudan S, Tekkis PP. Das Management von Rektumkarzinomen mit synchronen Lebermetastasen: ein modernes chirurgisches Dilemma. Tech Coloproctol. 2013;17:1-12.
46 Khan AZ, Morris-Stiff G, Makuuchi M. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg. 2009;16:137-44.
47 Folprecht G, Grothey A, Alberts S, Raab HR, Köhne CH. Neoadjuvante Behandlung von inoperablen kolorektalen Lebermetastasen: Korrelation zwischen Tumoransprechen und Resektionsraten. Ann Oncol. 2005;16:1311-9.
48 Stillwell AP, Buettner PG, Siu SK, Stitz RW, Stevenson AR, Ho YH. Prädiktoren der postoperativen Mortalität, Morbidität und des Langzeitüberlebens nach palliativer Resektion bei Patienten mit kolorektalem Karzinom. Dis Colon Rectum. 2011;54:535-44.
51 Stelzner S, Hellmich G, Jackisch T, Ludwig K, Witzigmann H. Selektive chirurgische Behandlung von Patienten mit Rektumkarzinom und inoperablen synchronen Metastasen basierend auf dem Ansprechen auf eine präoperative Chemotherapie. J Gastrointest Surg. 2008;12:1246-50.
52 Stillwell AP, Buettner PG, Ho YH. Meta-Analyse des Überlebens von Patienten mit kolorektalem Karzinom im Stadium IV, die mit chirurgischer Resektion versus alleiniger Chemotherapie behandelt wurden. World J Surg. 2010;34:797-807.
56 Ayez N, Burger JW, van der Pool AE, Eggermont AM, Grunhagen DJ, de Wilt JH, et al. Long-term results of the „liver first“ approach in patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum. 2013;56:281-7.
57 Al Bandar MH, Kim NK. Aktueller Stand und zukünftige Perspektiven der Behandlung von Lebermetastasen bei kolorektalem Karzinom (Review). Oncol Rep. 2017;37:2553-64.
58 Mattar RE, Al-Alem F, Simoneau E, Hassanain M. Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection. World J Gastroenterol. 2016;22:567-81.
60 Pawlik TM, Abdalla EK, Ellis LM, Vauthey JN, Curley SA. Debunking dogma: surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg. 2006;10:240-8.
61 Altendorf-Hofmann A, Scheele J. A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am. 2003;12:165-92.
62 Viganò L, Capussotti L, De Rosa G, De Saussure WO, Mentha G, Rubbia-Brandt L. Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival. Ann Surg. 2013;258:731-40.
63 Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative Chemotherapie mit FOLFOX4 und Chirurgie versus Chirurgie allein für resektable Lebermetastasen von kolorektalem Karzinom (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371:1007-16.
64 Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 2004;351:337-45.
65 Wagman LD. Bedeutung des Ansprechens auf eine neoadjuvante Therapie bei Patienten mit leberbegrenztem mCRC, wenn eine Resektion und/oder Ablation beabsichtigt ist. Clin Colorectal Cancer. 2013;12:223-32.
67 Mentha G, Roth AD, Terraz S, Giostra E, Gervaz P, Andres A, et al. „Liver first“ approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg. 2008;25:430-5.
68 van der Pool AE, de Wilt JH, Lalmahomed ZS, Eggermont AM, Ijzermans JN, Verhoef C. Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases. Br J Surg. 2010;97:383-90.
69 Hao CY, Ji JF. Chirurgische Behandlung von Lebermetastasen bei kolorektalem Karzinom: Strategien und Kontroversen im Jahr 2006. Eur J Surg Oncol. 2006;32:473-83.
70 Benoist S. Recommendations for clinical practice. Therapeutische Entscheidungen bei Rektumkarzinomen. Wie sollten Rektumkarzinome mit synchronen Metastasen behandelt werden? Gastroenterol Clin Biol. 2007;31:1s75-80s.
71 de Haas RJ, Adam R, Wicherts DA, Azoulay D, Bismuth H, Vibert E, et al. Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg. 2010;97:1279-89.
72 Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ, et al. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg. 2010;210:934-41.
73 Yoshidome H, Kimura F, Shimizu H, Ohtsuka M, Kato A, Yoshitomi H, et al. Interval period tumor progression: does delayed hepatectomy detect occult metastases in synchronous colorectal liver metastases? J Gastrointest Surg. 2008;12:1391-8.
74 Jatzko G, Wette V, Müller M, Lisborg P, Klimpfinger M, Denk H. Simultane Resektion von kolorektalem Karzinom und synchronen Lebermetastasen in einem Kreiskrankenhaus. Int J Colorectal Dis. 1991;6:111-4.
76 Hatwell C, Bretagnol F, Farges O, Belghiti J, Panis Y. Laparoscopic resection of colorectal cancer facilitates simultaneous surgery of synchronous liver metastases. Colorectal Dis. 2013;15:e21-8.
77 Wei M, He Y, Wang J, Chen N, Zhou Z, Wang Z. Laparoscopic versus open hepatectomy with or without synchronous colectomy for colorectal liver metastasis: a meta-analysis. PLoS ONE. 2014;9:e87461.
78 Roxburgh CS, Richards CH, Moug SJ, Foulis AK, McMillan DC, Horgan PG. Determinanten des Kurz- und Langzeitergebnisses bei Patienten, die sich einer gleichzeitigen Resektion von kolorektalem Karzinom und synchronen kolorektalen Lebermetastasen unterziehen. Int J Colorectal Dis. 2012;27:363-9.
79 Capussotti L, Vigano‘ L, Ferrero A, Lo Tesoriere R, Ribero D, Polastri R. Timing of resection of liver metastases synchronous to colorectal tumor: proposal of prognosis-based decisional model. Ann Surg Oncol. 2007;14:1143-50.
81 Hosseinali Khani M, Pahlman L, Smedh K. Treatment strategies for patients with stage IV rectal cancer: a report from the Swedish Rectal Cancer Registry. Eur J Cancer. 2012;48:1616-23.